Individual Stock News 1. Bilibili-W (09626.HK): Adjusted net profit for the first quarter increased by 62% year-on-year. 2. Federal Pharmaceuticals (03933.HK): TUL108 for injection received implied approval for clinical trials in China. 3. Chifeng

2026-05-20

Individual Stock News 1. Bilibili-W (09626.HK): Adjusted net profit for the first quarter increased by 62% year-on-year. 2. Federal Pharmaceuticals (03933.HK): TUL108 for injection received implied approval for clinical trials in China. 3. Chifeng Gold (06693.HK): The subscription price for new H shares was adjusted to HK$29.82 under a special authorization. 4. Beike-W (02423.HK) released its first-quarter results: Adjusted net profit of RMB 1.611 billion, an increase of 15.7% year-on-year. 5. Yushi Technology (01511.HK): The Hong Kong public offering was oversubscribed by 6777.29 times, and the global offering raised net proceeds of approximately HK$795.4 million. 6. Hesai-W (02525.HK): Net profit for the first quarter was RMB 18.3 million, compared to a loss of RMB 17.5 million in the same period last year, turning a profit year-on-year. 7. SF Holding (06936.HK): Revenue from express delivery, logistics, supply chain, and international businesses reached RMB 25.376 billion in April, a year-on-year increase of 6.11%. 8. Youjia Innovation (02431.HK): Signed a long-term cooperation agreement with Danyang High-tech Zone Industrial Company for the purchase of 200 unmanned logistics vehicles. 9. ZTO Express (02057.HK): First-quarter revenue reached RMB 13.28 billion, a year-on-year increase of 22%. It expects express delivery volume to increase by 10% to 13% year-on-year in 2026, with a volume range of 42.37 billion to 43.52 billion pieces. 10. Huanxi Media (01003.HK) plans to issue 731 million subscription shares to Paradigm Intelligent (06682.HK) and enter into a strategic cooperation and joint venture framework agreement.